New gel could treat parasitic skin sores without pills
Disease control
Not yet recruiting
This early-stage study tests whether a gel containing the drug miltefosine can safely treat skin sores from cutaneous leishmaniasis, a parasitic disease. Fifteen adults with 1-4 sores will apply the gel daily for 28 days and be monitored for healing and side effects. The goal is …
Phase: PHASE1 • Sponsor: Universidad Industrial de Santander • Aim: Disease control
Last updated May 14, 2026 12:02 UTC